CME Group (NASDAQ:CME) PT Raised to $209.00 at Barclays

CME Group (NASDAQ:CME) had its price objective raised by Barclays from $208.00 to $209.00 in a research report report published on Thursday, Benzinga reports. The brokerage currently has an equal weight rating on the financial services provider’s stock.

Several other analysts also recently commented on the stock. JPMorgan Chase & Co. downgraded shares of CME Group from a neutral rating to an underweight rating and decreased their price objective for the company from $206.00 to $187.00 in a research report on Friday, June 21st. Keefe, Bruyette & Woods reissued a market perform rating and set a $226.00 price target on shares of CME Group in a report on Wednesday, July 3rd. Morgan Stanley upped their price objective on CME Group from $222.00 to $225.00 and gave the stock an equal weight rating in a research note on Tuesday, April 9th. Piper Sandler decreased their target price on CME Group from $235.00 to $225.00 and set an overweight rating on the stock in a research note on Thursday. Finally, Rosenblatt Securities restated a sell rating and issued a $187.00 price target (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of Hold and a consensus price target of $212.64.

CME Group Stock Up 0.6 %

Shares of CME stock opened at $200.54 on Thursday. CME Group has a 12 month low of $190.70 and a 12 month high of $223.80. The stock has a market cap of $72.21 billion, a P/E ratio of 22.81, a P/E/G ratio of 6.65 and a beta of 0.52. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a 50 day simple moving average of $199.87 and a two-hundred day simple moving average of $207.06.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the prior year, the company earned $2.30 earnings per share. The firm’s revenue was up 12.7% on a year-over-year basis. On average, research analysts expect that CME Group will post 9.8 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.29%. The ex-dividend date was Friday, June 7th. CME Group’s dividend payout ratio is presently 52.33%.

Insider Activity at CME Group

In related news, Director Terry L. Savage sold 2,500 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the completion of the transaction, the director now owns 17,441 shares of the company’s stock, valued at approximately $3,673,946.65. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Terry L. Savage sold 2,500 shares of the stock in a transaction on Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the sale, the director now owns 17,441 shares in the company, valued at approximately $3,673,946.65. The disclosure for this sale can be found here. Insiders have sold a total of 14,290 shares of company stock valued at $2,957,300 over the last 90 days. 0.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. B. Riley Wealth Advisors Inc. grew its holdings in CME Group by 1.3% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after purchasing an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC boosted its position in shares of CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after buying an additional 48 shares during the period. Lantz Financial LLC grew its stake in shares of CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after buying an additional 49 shares during the last quarter. Transcend Capital Advisors LLC raised its holdings in shares of CME Group by 1.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after buying an additional 50 shares during the period. Finally, Lester Murray Antman dba SimplyRich lifted its stake in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.